Ralmitaront

N/A

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug NameRalmitaront
Drug Alias NameRO-6889450RG-7906NTX-2001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTrace amine-associated receptor 1 agonists
TargetsTrace amine-associated receptor 1
Therapy Area/IndicationsSchizophreniaAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraineNetherlands +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNewleos Therapeutics IncF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaAlcoholism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A